Skip to main content
. 2023 Mar 3;15(5):1579. doi: 10.3390/cancers15051579

Table 2.

Clinical applications of ctDNA, ctRNA and EVs.

Cancer Markers Technique References
ctDNA Breast ERBB2, BRCA1, TP53, PIK3CA NGS
Tam-Seq
[126]
[127]
Colorectal BRAF, KRAS, APC, TP53, CEA, and SEPTIN9 Sanger Sequencing, Epi proColon Assay [126]
Gastric ERBB2, FGFR1, CDH1, PIK3CA, MET, KDR, TP53, and TFDP-1 qPCR
CellSearch
[126]
[128]
Gliomas IDH1, EGFR, KRAS, MGMT qRT-PCR, ddPCR, BEAMing [129]
Head and neck TP53, PIK3CA, NOTCH1, FBXW7, CDKN2A, NRAS and HRAS NGS [130,131]
Hepatocellural TP53, CTNNB1, PTEN, CDKN2, ARID1A, MET, CDK6, EGFR, MYC, BRAF, RAF1, FGFR1, CCNE1, PIK3CA and ERBB2 Sanger Sequencing, Mass Spectrometry, qPCR [126]
Lung EGFR, ALK, BRAF, KRAS, ERBB2, PIK3CA, FGFR1, KRAS, ROS1, MET, RET and TP53 NGS
ddPCR
[132,133,134]
Pancreatic KRAS, BRAF NGS
ddPCR
WES
[131,135,136]
Prostate TP53, RB1, PTEN, AR, FOXA1, MYC, ERG, PIK3CA, and WNT1 CellSearch [137]
RNA Colorectal miR-548c-5p, miR-21, CRNDE-h, lncRNA GAS5, miR-19, miR-221, lncRNA 91H, miR-23a, miR-1224-5p, miR-6803, Let-7a, miR-1229 qRT-PCR [138,139,140,141]
Gastric lncUEGC1, lncUEGC2, HOTTIP, ZFAS1, miR-423-5p, miR-451, miR23b qRT-PCR [142,143,144,145]
Pancreatic MiR-125b-5p, miR-21, circPDE8A, miR-451a, miR-191, miR-17-5p qRT-PCR [146,147,148]
Liver hnRNPH1, LINC00161, LINC00635, TERT, miR-638, miR-125b, miR-93 qRT-PCR [149,150,151]
Laryngeal HOTAIR qRT-PCR [152]
Prostate MiR-1290, miR-375, miR-125, miR-19b, SAP30L-AS1, SChLAP1, LincRNA-p21 qRT-PCR [153,154]
Ovarian miR-200a, miR-200b, miR-200c, miR-21, miR-100, miR-326 PCR, qRT-PCR [155]
Lung miR-451a, miR-23b-3p, miR-21-5p, miR-10b-5p, MALAT-1 qRT-PCR [156,157]
Multiple Myeloma let-7b, let-7e, miR-106a, miR-106b, miR-155, miR-16, miR-17, miR-18a, miR-20a qRT-PCR [158]
Glioma miR-301a qRT-PCR [159]
Glioblastoma RNU6 qRT-PCR [160]
EVs proteins Colorectal CPNE3, GPC1 ELISA [161,162]
Pancreatic GPC1 Flow cytometry [163]
Lung CD171, 14-3-3ζ, Flotilin 1, HER3, GRP78 ELISA [164,165]
Ovarian ephrin A2 ELISA [166]
Prostate ADIRF, TMEM256 Mass spectrometry [167]
Melanoma exo-MIA, exo-5100B ELISA [168]
Bladder TACSTD2 ELISA [169]
Breast ERBB2, BCRP, Fibronectin, Periostin, Del-1 Flow cytometry
ELISA
[170,171,172]